Dr. Soliman Abdel Kader Fakeeh Hospital Past Earnings Performance
Past criteria checks 2/6
Dr. Soliman Abdel Kader Fakeeh Hospital has been growing earnings at an average annual rate of 1.1%, while the Healthcare industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 20.8% per year. Dr. Soliman Abdel Kader Fakeeh Hospital's return on equity is 7.7%, and it has net margins of 10.6%.
Key information
1.1%
Earnings growth rate
-20.7%
EPS growth rate
Healthcare Industry Growth | 12.3% |
Revenue growth rate | 20.8% |
Return on equity | 7.7% |
Net Margin | 10.6% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dr. Soliman Abdel Kader Fakeeh Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2,586 | 274 | 346 | 0 |
31 Mar 24 | 2,478 | 280 | 323 | 0 |
31 Dec 23 | 2,327 | 280 | 304 | 0 |
30 Sep 23 | 2,205 | 311 | 234 | 0 |
31 Dec 22 | 2,012 | 326 | 198 | 0 |
31 Dec 21 | 1,965 | 334 | 231 | 0 |
31 Dec 20 | 1,715 | 203 | 203 | 0 |
31 Dec 19 | 1,640 | 301 | 238 | 0 |
Quality Earnings: 4017 has high quality earnings.
Growing Profit Margin: 4017's current net profit margins (10.6%) are lower than last year (14.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4017's earnings have grown by 1.1% per year over the past 5 years.
Accelerating Growth: 4017's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4017 had negative earnings growth (-13.3%) over the past year, making it difficult to compare to the Healthcare industry average (36.5%).
Return on Equity
High ROE: 4017's Return on Equity (7.7%) is considered low.